Showing results (831-840 of 3,701) with videos related to
Sort By:
Pageof 371
International Journal of Clinical Oncology|April 12, 2024
English version of Japanese Clinical Practice Guidelines 2022 for gastrointestinal stromal tumor (GIST) issued by the Japan Society of Clinical OncologySeiichi Hirota, Ukihide Tateishi, Yuji Nakamoto, et al.International Journal of Clinical Oncology|April 17, 2024
New therapeutic target molecules for gastric and gastroesophageal junction cancerHisato KawakamiInternational Journal of Clinical Oncology|April 16, 2024
Early experience and future prospects regarding use of newly developed surgical robot system, hinotori, in the field of urologic cancer surgeryHideaki Miyake, Masato FujisawaInternational Journal of Clinical Oncology|May 10, 2024
Safety and efficacy of neoadjuvant chemotherapy with paclitaxel, carboplatin, and cetuximab for locally advanced head and neck squamous cell carcinomaRyoko Tanaka, Yushi Ueki, Shusuke Ohshima, et al.International Journal of Clinical Oncology|May 6, 2024
Risk factors for lymph node metastasis in T2 colorectal cancer: a systematic review and meta-analysisJun Watanabe, Katsuro Ichimasa, Shin-Ei Kudo, et al.International Journal of Clinical Oncology|May 2, 2024
Therapeutic use of granulocyte colony-stimulating factor (G-CSF) in patients with febrile neutropenia: a comprehensive systematic review for clinical practice guidelines for the use of G-CSF 2022 from the Japan Society of Clinical OncologyKenji Tsuchihashi, Mamoru Ito, Yuta Okumura, et al.International Journal of Clinical Oncology|April 28, 2024
Optimal surgical approach for mid-transverse colon cancer: a systematic review and meta-analysisBeshoy Effat Elkomos, Philopateer Effat Alkomos, Mina Fransawy Alkomos, et al.International Journal of Clinical Oncology|April 30, 2024
Relationship between HER2-low status and efficacy of CDK4/6 inhibitors in advanced breast cancer: a real-world studyT Önder, Ö Ateş, I Öner, et al.International Journal of Clinical Oncology|April 8, 2024
Psoas mass index at the level of the third lumbar vertebra on computed tomography is a prognostic predictor for metastatic castration-sensitive prostate cancerShunsuke Owa, Takeshi Sasaki, Ryota Ikadai, et al.International Journal of Clinical Oncology|April 6, 2024
Impact of disease volume on survival efficacy of triplet therapy for metastatic hormone-sensitive prostate cancer: a systematic review, meta-analysis, and network meta-analysisAkihiro Matsukawa, Pawel Rajwa, Tatsushi Kawada, et al.Pageof 371